Found 7 matching trials
Expanded Access Program (EAP) for Galinpepimut-S (GPS) in Patients Diagnosed With AML or MDS
N/ASingle patient expanded access program to provide galinpepimut-S for eligib...
Location
Multiple Locations
WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)
PHASE2This trial will assess the safety and efficacy of vaccination with galinpep...
Location
Memorial Sloan Kettering Cancer Center
Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy
PHASE2Study of galinpepimut-S, a Wilms Tumor-1 (WT1) vaccine, to see if it delays...
Location
Memorial Sloan Kettering Cancer Center
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
PHASE3To assess the safety and efficacy of galinpepimut-S (GPS) compared with inv...
Status
Active Not Recruiting
Location
O'Neal Comprehensive Cancer Center
WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation
PHASE1The purpose of this trial is to assess the immune response after vaccinatio...
Location
Memorial Sloan Kettering Cancer Center
Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers
PHASE1To evaluate the safety, tolerability, and anti-tumor activity of galinpepim...
Location
St. Joseph Heritage Healthcare
Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma
PHASE1The purpose of this study is to test whether it is safe to give Galinpepimu...
Location
Memorial Sloan Kettering Basking Ridge